GlassScriptPhysician profile
Tanner A Evans
NPI 1770930364
$729.44
in general payments reported to CMS, 2019-2025
14 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $70.53 · 2022: $180 · 2023: $130 · 2024: $50.94 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $145.49 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $121.06 | 2021-2025 | Farxiga, Airsupra |
| Smith+Nephew, INC. | $91.36 | 2022-2025 | Grafix Pl |
| Biogen, INC. | $77.82 | 2025 | Zurzuvae |
| Lilly USA, LLC | $56.19 | 2023-2025 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $55.13 | 2022 | |
| Pfizer INC. | $37.35 | 2023-2025 | |
| Sanofi Pasteur INC. | $29.09 | 2022-2023 | |
| Biohaven Pharmaceuticals, INC. | $26.43 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.73 | 2025 | |
| Innovation Technologies INC | $19.33 | 2023 | Irrisept |
| Biohaven Pharmaceutical Holding Company LTD. | $19.20 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.86 | 2022 | |
| Mylan Specialty L.P. | $15.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.